XTX Topco’s Cymabay Therapeutics CBAY Stock Holding History

XTX Topco’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,767	Closed	-$254K	–	2470
2023 Q4	$254K	Sell	10,767 -7,809	-42%	-$139K	0.06%	762
2023 Q3	$277K	Buy	+18,576	New	+$246K	0.05%	782
2022 Q3	–	Sell	-34,563	Closed	-$102K	–	1458
2022 Q2	$102K	Buy	34,563 +17,380	+101%	+$41.5K	0.04%	641
2022 Q1	$53K	Buy	+17,183	New	+$54.1K	0.02%	587
2021 Q3	–	Sell	-33,658	Closed	-$147K	–	1150
2021 Q2	$147K	Buy	33,658 +14,281	+74%	+$63.3K	0.05%	607
2021 Q1	$88K	Buy	+19,377	New	+$104K	0.04%	578

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's CBAY Position: Q1 2024 in Review

XTX Topco sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 10,767 shares — an estimated $254K sold.

XTX Topco first reported a position in CBAY in Q1 2021 and held it in 6 quarters. The position peaked at $277K in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

XTX Topco reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
XTX Topco sold 10,767 Cymabay Therapeutics shares in Q1 2024, an estimated $254K.
XTX Topco first reported a position in Cymabay Therapeutics in Q1 2021 and held it in 6 quarters.
XTX Topco's Cymabay Therapeutics position peaked at $277K in Q3 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.